Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Active, not recruiting · NCT05577312 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-21 | NCT05577312 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences | Tianjin | China | 1 |
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 1 |
| No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital | Nanning | China | 2 |
| Shenzhen Children 's Hospital | Shenzhen | China | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit | Guanzhou | China | 1 |
| The First Affiliated Hospital of Guangxi Medical University | Nanning | China | 66 |
| Xiangya Hospital of Central South University | Changsha | China | 3 |